Rating History for YS Biopharma Co. (YS) by Noble Capital
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/13/2023 | N/A | New Coverage | Outperform (N/A) |
5.25 (N/A) |
0.60 (1.02) |
70% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/13/2023 | N/A | New Coverage | Outperform (N/A) |
5.25 (N/A) |
0.60 (1.02) |
70% | Details |